Illustration: AI-generated · Inside China AI
Unitree: The $9 Billion Company Behind the Viral Robots
Part of China’s Humanoid Seven — our complete guide to the seven companies that define China’s humanoid industry.
Update, August 19: Unitree debuted on the STAR Market today after a record 8,000-fold oversubscription — the first humanoid robotics listing on a mainland Chinese exchange, at a $9 billion valuation with Tencent among the strategic investors.
Most Europeans met Unitree through viral videos: robot dogs doing backflips, humanoids performing kung-fu at China’s Spring Festival Gala in front of roughly 679 million viewers. It would be a mistake to file the company under entertainment. In August 2026, Unitree became the first humanoid robotics stock on China’s A-share market, pricing its Shanghai STAR Market IPO at a valuation of around 61 billion yuan (roughly $9 billion) — and turning its 36-year-old founder Wang Xingxing into what Forbes called China’s first humanoid-robot billionaire.
From a master’s thesis to the industry’s price-setter
Wang Xingxing founded Unitree in Hangzhou in 2016, building on a robot he had developed as a graduate student. The company spent its first years making quadrupeds — the Go and B series that became the reference products of the category — before pivoting its ambitions to humanoids. That heritage matters: Unitree industrialised legged locomotion earlier than almost anyone, and it shows in the pricing.
Pricing is the strategy. The R1 humanoid starts at around $4,900, the G1 at $13,500 — figures that western competitors do not currently approach. The taller H2 lists at $29,900, while the H2 Plus serves as NVIDIA’s GR00T reference robot. Unitree is betting that affordable hardware wins the developer ecosystem first and the applications later — the same logic that made Qwen dominant in open-weight AI models.
Key numbers (H1 2026)
- ~5,900 humanoids shipped in H1 2026 — 31% global share, second only to AgiBot, per research firm SAG; Unitree had led the full year 2025 with a 32.4% share
- 2025 revenue of ¥1.71 billion (+335% year on year), with adjusted net income of roughly ¥600 million — a profitable humanoid maker, still a rarity
- IPO priced August 6, 2026 at 150.80 yuan per share, raising ~¥6.1 billion at a ~¥61 billion valuation
- Top-5 patent portfolio among humanoid start-ups worldwide, per LexisNexis’ July 2026 Patent Asset Index
The DeepSeek alliance
In August 2026, DeepSeek — Unitree’s Hangzhou neighbour and China’s most famous AI lab — invested ¥140.8 million as a strategic IPO investor. The two companies agreed to jointly develop an AI “robot brain” for Unitree’s humanoids, with a mutual preferred-supplier arrangement. It is one of the clearest signals yet that China’s frontier-model labs and its robotics leaders are converging on embodied AI as the next platform.
Why Unitree matters
Unitree defines the cost curve of the entire humanoid industry. Every western competitor is now measured against its price points, and its volume strategy — up to 20,000 humanoids targeted for 2026 — is designed to make humanoids a developer commodity before rivals reach production scale. The combination of profitability, public-market capital and a frontier-lab AI partner makes it the most complete platform bet in the category. Related: why carmakers are becoming robot makers.
The European angle
Unitree sells into Europe through a distributor network and launched its commercial humanoid offering in Europe in July 2026. At the same time, the company sits squarely in the geopolitical crossfire: US authorities have moved to restrict Chinese humanoid imports, and a US House hearing in July examined Unitree and DeepSeek as national-security concerns. European buyers — universities, integrators, industrial pilots — will find the most affordable humanoids on the market here, but should factor regulatory divergence between the US and EU into any procurement decision. For now, Europe remains open terrain, and Unitree is moving into it faster than most European decision-makers realise.
No responses yet